Literature DB >> 29714640

Cannabis in End-of-Life Care: Examining Attitudes and Practices of Palliative Care Providers.

Rachel Luba1, Mitch Earleywine1, Stacey Farmer1, Melissa Slavin1.   

Abstract

Medical cannabis research has become quite extensive, with indications ranging from glaucoma to chemotherapy-induced nausea. Despite increased interest in cannabis' potential medical uses, research barriers, cannabis legislation, stigma, and lack of dissemination of data contribute to low adoption for some medical populations. Of interest, cannabis use appears low in palliative care settings, with few guidelines available to palliative care providers. The present study sought to examine the attitudes, beliefs, and practices of palliative care providers regarding the use of cannabis for terminally ill patients. Palliative care providers (N = 426) completed a one-time online survey assessing these attitudes, beliefs, and practices. Results demonstrated that palliative care providers endorse cannabis for a wide range of palliative care symptoms, end-of-life care generally, and as an adjuvant medication. Nevertheless, the gap between these beliefs and actual recommendation or prescription appears vast. Many who support the use of cannabis in palliative care do not recommend it as a treatment. These data suggest recommendations for healthcare providers and palliative care organizations.

Entities:  

Keywords:  Cannabis; end-of-life care; palliative care

Mesh:

Substances:

Year:  2018        PMID: 29714640     DOI: 10.1080/02791072.2018.1462543

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  5 in total

1.  Knowledge, Practices, and Attitudes of Washington State Health Care Professionals Regarding Medical Cannabis.

Authors:  Louise Kaplan; Tracy Klein; Marian Wilson; Janessa Graves
Journal:  Cannabis Cannabinoid Res       Date:  2020-06-05

2.  Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer.

Authors:  Rebecca E Olson; Alexandra Smith; Georgie Huggett; Phillip Good; Morgan Dudley; Janet Hardy
Journal:  Trials       Date:  2022-09-05       Impact factor: 2.728

3.  Patient-Related Barriers to the Prescription of Cannabinoid-Based Medicines in Palliative Care: A Qualitative Approach.

Authors:  Pauline Kalonji; Aurélie Revol; Barbara Broers; Michael Ljuslin; Sophie Pautex
Journal:  Palliat Med Rep       Date:  2022-09-16

4.  Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis - A systematic review.

Authors:  Kyle M Gardiner; Judith A Singleton; Janie Sheridan; Gregory J Kyle; Lisa M Nissen
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

5.  Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms.

Authors:  David J Casarett; Jessica N Beliveau; Michelle S Arbus
Journal:  J Palliat Med       Date:  2019-08-06       Impact factor: 2.947

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.